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This is a 12-year follow-up cohort study with 800 people (60–85 years old). The association between lipid disorders and mortality
was analysed by Cox proportional hazard adjusted model. All-cause mortality was considered the dependent variable, and lipid
disorders as independent variables: total cholesterol (TC) >200 and <170mg/dl, HDL-c <35 and 40, LDL-c >100 and 130, and
triglycerides (TG) >50. An initial analysis of all subjects was performed and a second was carried out after having excluded
individuals with a body mass index (BMI) <20kg/m2 or mortality in ≤2 years. The mortality showed a positive association with
low TC and a negative association with high TC and high LDL-c. After the exclusion of underweight and premature mortality,
there was a positive association only with TC <170mg/dl (HR = 1.36, CI95%: 1.02–1.82). The data did not show a higher risk with
high levels of TC, LDL-c, and TG. However, they showed higher mortality among older adults with low TC.
1.Introduction
Dyslipidemias, particularly hypercholesterolemia, hyper-
triglyceridemia, and low high density lipoprotein cholesterol
(HDL-c), are known as important risk factors for cardio-
vascular morbidity and mortality among the population in
general [1] and have recently been associated with some
chronic degenerative diseases such as dementias [2].
However, the role that lipid disorders play as mortality
risk factors in older adult populations is not very clear
[3], even though they present the highest morbidity and
mortality rates.
There is some evidence that the relation between total
cholesterol (TC) and all-cause mortality varies according to
age. Kronmal et al. suggested that although there is a positive
relation (high TC and high mortality) at age 40, the direction
of the risk becomes negative by age 80 (high TC and low
mortality) [4]. This inversion of high TC risk in very old
people has been conﬁrmed by other authors [5].
Low TC has been identiﬁed as a risk factor for older
adult mortality but is commonly attributed to the fact that
low TC levels indicate malnutrition, chronic infections, and
subclinical or hidden diseases [6, 7].
Theobjectiveofthisstudywastoanalyzetheriskofdeath
fromlipiddisordersinolderpeopleupto85yearsofageover
a 12-year follow-up period.
2.MaterialsandMethods
2.1. Participants and Setting. Observational prospective
cohort study with 800 individuals between 60 and 85 years
old who were treated at two geriatric clinics in the city of
Londrina, PR, Brazil. Baseline: June/1997 to July/1998; end
point: march 2010. Those with diagnosed active neoplastic
disease (except skin and prostate neoplasm) or diﬃculty
standing for the anthropometric measurements were exclud-
ed beforehand.
2.2. Measurements at the Baseline Examination. The vari-
ables gender, age, and smoking were evaluated, as well as the
presence of diabetes, hypertension, and previous cardiovas-
cular disease (heart failure, coronary diseases, arrhythmias,2 The Scientiﬁc World Journal
Table 1: Characterization of older people according to sex.
Total (n = 800) Men (n = 266) Women (n = 534) P
Age (mean)—years 71.2 70.9 71.3 ns
Hypertension (%) 53.9 47.4 57.1 <0.05
Diabetes (%) 14.9 14.2 15.2 ns
Previous cardiovascular diseases (%) 17.1 19.8 15.7 ns
Smoking (%) 7.6 12.8 5.1 <0.001
BMI (kg/m2) 25.9 25.0 26.4 <0.001#
Total cholesterol (mg/dL) 205.8 194.7 211.2 <0.001
HDL-c (mg/dL) 49.9 44.8 52.4 <0.001
LDL-c (mg/dL) 126.6 121.1 129.3 <0.05
Cholesterol non-HDL-c (mg/dL) 155.7 149.9 158.6 <0.05
Triglycerides (mg/dL) 146.5 144.0 147.8 ns
All-cause mortality (%) 42.4 48.9 39.1 <0.05
BMI: body mass index; HDL-c: high density lipoprotein cholesterol; LDL-c: low density lipoprotein cholesterol; ns: nonsigniﬁcant; #Kruskal-Wallis test.
pacemaker, myocardial infarct, and stroke). Height and
weight were measured and body mass index was calculated
(BMI).
Serum lipoprotein levels (total cholesterol, HDL-c and
triglycerides) were measured using standard enzymatic tech-
niques. Based on this information, the following variables
were calculated: non-HDL-c cholesterol (total cholesterol—
HDL-c) and low-density lipoprotein cholesterol (LDL-c)
[8]. Regarding analysis of LDL-c, 14 elderly people with
triglycerides >400mg/dL were excluded.
Lipid alterations were classiﬁed and analyzed according
to the following values [1]:
(i) total Cholesterol (TC) ≥200mg/dL,
(ii) total cholesterol (TC) <170mg/dL,
(iii) high-density lipoprotein cholesterol (HDL-c)
<40mg/dL,
(iv) high-density lipoprotein cholesterol (HDL-c)
<35mg/dL,
(v) low-density lipoprotein cholesterol (LDL-c)
>130mg/dL,
(vi) low-density lipoprotein cholesterol (LDL-c)
>100mg/dL,
(vii) cholesterol non-HDL-c (non-HDL-c) >170mg/dL,
(viii) triglycerides (TG) >150mg/dL,
(ix) triglycerides (TG) >200mg/dL.
2.3. Followup. During the entire the followup period, the
older adults were monitored every six months by means of
either phone calls or medical appointment.
Individuals who were not found after an active search
using addresses, health insurance, retirement, and mortality
data were considered as losses and censured in the analysis
model subsequent to the last followup contact date.
2.4. Statistical Analysis. Data were stored and analyzed using
the program EPINFO—version 3.5. The signiﬁcance level
was set at 5%. The chisquare test was used to compare
the sample characteristics according to gender for categor-
ical variables. Analysis of variance (ANOVA) was used to
compare numerical variables with homogenous variances;
otherwise the Kruskal-Wallis test was used.
Cumulative survival probability was computed using
Cox proportional hazards modeling; the outcome analyzed
was all-cause mortality and the independent variables were
dyslipidemias, which were presented as categorical variables.
The regression model was adjusted for gender, age range >75
years old, hypertension, and diabetes.
A second analysis was carried out with a model adjusted
for gender, age range, hypertension and diabetes, but exclud-
ing the older people who died in the ﬁrst two years or whose
BMI dropped to <20kg/m2.
Thepurposeforexcludingpatientswhodiedprematurely
or became underweight was to reduce the impact of pre-
existing diseases as the cause of death and to minimize the
interference of low weight on cholesterol levels, malnutrition
and mortality.
2.5. Ethical Aspects. This study was approved by the Ethics
CommitteeoftheUniversidadeEstadualdeLondrina,andall
patients provided written informed consent at the beginning
of followup.
3. Results
The sample consisted of 800 individuals from 60 to 85
years old (mean age = 71.2; median = 70.5) and was
predominantly female (66.7%). Mean followup time for
those whose outcome was not presented was 146.6 months.
Followup with 38 people was lost (4.8%).
Three-hundred thirty-nine deaths were registered
(42.9%), being more frequent among men (48.9%). Mean
TC, non-HDL-c, HDL-c, and LDL-c were higher among
women. High blood pressure was more frequent among
women and smoking was more frequent among men
(Table 1).
In the Cox proportional hazard analysis adjusted for
gender, age range >75 years, hypertension, and diabetes,
there was a positive association between mortality and theThe Scientiﬁc World Journal 3
Table 2: All-cause mortality risk and lipid levels in adjusted by sex, age >75, hypertension, and diabetes.
Variable Hazard ratio Conﬁdence interval 95% Value of P
Total cholesterol >200mg/dL 0.76 0.61–0.95 <0.05
Total cholesterol <170mg/dL 1.60 1.26–2.04 <0.001
HDL-c <40mg/dL 1.20 0.93–1.54 ns
HDL-c <35mg/dL 1.21 0.90–1.63 ns
Cholesterol non-HDL >170mg/dL 0.78 0.61–0.99 <0.05
LDL-c >100mg/dL 0.69 0.55–0.87 <0.05
LDL-c >130mg/dL 0.73 0.58–0.92 <0.05
Triglycerides >150mg/dL 0.82 0.65–1.03 ns
Triglycerides >200mg/dL 0.81 0.59–1.11 ns
HDL-c: high density lipoprotein cholesterol; LDL-c: low density lipoprotein cholesterol.
ns: nonsigniﬁcant.
total cholesterol <170mg/dL variable. The variables total
cholesterol >200mg/dL, cholesterol non-HDL >170mg/dL,
and LDL-c >130 and >1 0 0m g / d Lw e r en e g a t i v e l ya s s o c i a t e d
with mortality (Table 2).
After excluding 116 individuals who died prematurely
(<2 years) or were underweight (BMI <20kg/m2), the only
variable presenting positive association with mortality was
total cholesterol <170mg/dL (P = 0.04). In this stratiﬁed
analysis, no variable presented a statistically signiﬁcant
negative association with mortality (Table 3).
4. Discussion
The results indicate higher mortality among older people
withlowerlevelsoftotalcholesterol.Furthermore,theyshow
no association between all-cause mortality and hypercholes-
terolemia, high LDL-c, low HDL-c, hypertriglyceridemia,
and high non-HDL-c in this group of older adults.
High levels of lipoproteins such as TC, LDL-c, and TG
are widely known as risk factors for total and cardiovas-
cular mortality in the general population [1]. In geriatric
populations, however, this association is being studied, and
conﬂicting results have been presented. These results depend
on methodological characteristics such as age, follow-up
time, and the covariables analyzed [7–11].
Our results did not show a positive association between
hyperlipidemias and all-cause mortality. In the initial anal-
ysis, even before excluding premature mortality and under-
weight individuals, this association was negative.
Questions persist about the real role of hypercholes-
terolemia as a general mortality risk among older people;
the association may be positive, negative, or null. The fact
that other authors have not observed a positive association
corroborates our results [8, 9, 11].
Concerningtheriskofdevelopingcardiovasculardisease,
there is more evidence of the role of TC increase in the
geriatric population [12, 13]. It is possible that among
elderly populations, high TC levels are associated with better
global health conditions. In a study carried out in Honolulu,
researchers observed that high TC levels were associated
with higher body mass index levels, high HDL-c, better
hemoglobin levels, and greater muscular strength [7].
Another factor that could inﬂuence analysis of lipid risk
factors in older people is cardiovascular mortality before age
60 among individuals with high cholesterol.
Inaddition tonotshowing amortality increase withhigh
liproprotein levels, data from the present study indicate that
there is a higher risk in low lipoprotein levels such as TC and
HDL-c.
Low HDL-c levels have already been established as
determinants of cardiovascular morbimortality among geri-
atric populations [14, 15] .I nt h i ss t u d y ,w eh a v eo b s e r v e d
that even using two diﬀerent HDL-c cut-oﬀs( <35 and
40mg/mL) [1], there was positive association with all-
cause mortality, although not statistically signiﬁcant. This
corroborates the results of other authors who have observed
a similar association in samples of people aged 65 or older
[16], 70 or older [17], and in the frail elderly [18].
Low TC levels represented an important mortality pre-
dictor in our analysis of 800 older people (HR = 1.60; CI95%
1.26–2.04). Low TC is related to nutritional deﬁciencies and
poorgeneralhealth,whichcouldjustifythispoorprognostic.
Nevertheless, the association remained positive in a
second analysis after exclusion of individuals with BMI
<20.0kg/m2or of cases that died in the ﬁrst two years.
Persistence of risk even after these exclusions could suggest
that low-serum TC represents a poor prognostic indicator
independent of association with subclinical or hidden dis-
eases and even nutritional deﬁciency, which by itself would
represent an important risk factor in this age range.
T h er o l eo fl o wc h o l e s t e r o la sar i s km a r k e ro fm o r t a l i t y
among older people has also been analyzed by other authors
who used diﬀerent methodologies. Tuikkala et al. analyzed
a n df o l l o w e du pag r o u po fh o m e - d w e l l i n ge l d e r l yp e r s o n s
for six years and found a positive association between low
TC and all-cause mortality, independently of comorbidities
and general health condition [19]. Like our results, this
data reinforces the role of low cholesterol as an indicator
of higher mortality risk without necessarily being associated
with previous clinical situations.
This possibility has beenreinforcedbyanotherstudy that
suggested low TC as an independent mortality predictor in
the elderly. Even though their sample was small, the authors4 The Scientiﬁc World Journal
Table 3: All-cause mortality risk and lipid levels in adjusted by sex, age >75, hypertension, and diabetes (excluded body mass index
<20kg/m2 and early mortality <2 years).
Variable Hazard ratio Conﬁdence interval 95% Value of P
Total cholesterol >200mg/dL 0.84 0.65–1.09 ns
Total cholesterol <170mg/dL 1.36 1.02–1.82 <0.05
HDL-c <40mg/dL 1.28 0.97–1.70 ns
HDL-c <35mg/dL 1.34 0.96–1.85 ns
Cholesterol Non-HDL >170mg/dL 0.88 0.67–1.16 ns
LDL-c >100mg/dL 0.83 0.63–1.10 ns
LDL-c >130mg/dL 0.81 0.62–1.05 ns
Triglycerides >150mg/dL 0.89 0.68–1.16 ns
Triglycerides >200mg/dL 0.86 0.60–1.23 ns
HDL-c: high density lipoprotein cholesterol; LDL-c: low density lipoprotein cholesterol; ns: nonsigniﬁcant.
demonstrated that after the exclusion of patients with acute
diseases, dementia, infection, and malnutrition, low TC was
associated with higher mortality within a 2-year period [20].
Positive association between low TC and all-cause mor-
tality was also identiﬁed among elderly Italians of an age
range similar to that of the participants in the present study
(mean of 73 years, excluding those 85 or older), but with
shorter follow-up time (3 years) [21].
Also, within a short three-year follow-up period, nonde-
mented older people with lower TC, non-HDL-c and LDL-
c levels had a higher mortality risk, even after adjusting for
heart diseases, smoking, and diabetes. Levels of association
with mortality were no diﬀerent among those older than
75, and this association was mitigated by the exclusion of
mortality in the ﬁrst year [9].
Volpato et al. showed higher mortality risk with low
TC and suggested the inclusion of serum albumin and
HDL-c values in the clinical evaluation to enhance the risk
represented by low TC [22].
Akerblometal.analyzedagroupofolderpeoplefora12-
year follow-up period and identiﬁed that low TC, non-HDL-
c, and LDL-c levels were associated with higher mortality
among white and black subjects but not among Hispanics
[11]. The lipid cutoﬀ levels in their study were similar to
those used in the present analysis.
In general, the values used to describe low TC levels were
similar in all the studies presented (160 to 180mg/dL); in
the present study, we used the cut-oﬀ <170mg/dL, which
corresponded to that used by other authors.
Some methodological characteristics of this study
deserve attention for appropriate extrapolation of the data
obtained in this analysis. Due to the long follow-up period, it
was possible to observe outcomes after many years, reducing
the possibilities of events having happened due to previous
disease situations. The exclusion of subjects older than 85
in a follow-up study is necessary to minimize the eﬀects of
expected high mortality of very old people during the time
of the study.
It is important to highlight some limitations that could
have inﬂuenced the results of this analysis such as non-
acknowledgment of the use of lipid-lowering drugs, other
comorbidities, and smoking.
In spite of the fact that the sample was composed by
outpatients, some demographic, lifestyle, and comorbidities
characteristics are similar to those of the general elderly
population. Therefore, it seems reasonable to extrapolate
these results to larger older populations.
Based on what we observed, we conclude that the
reduction of TC levels can be interpreted as an indirect risk
marker of morbidity and mortality in apparently healthy
older individuals.
Therefore, low or declining total cholesterol tests could
be used in clinical practice for decision making regarding
further nutritional investigation as well as to track hidden
diseases such as malignant neoplasms. However, the results
of this study suggest that, even without such aggravating fac-
tors, older people with low TC represent a more vulnerable
group.
Another aspect to be considered in clinical practice is
the pertinence of pharmacological measures for reducing TC
levelsin primary andsecondaryprevention of cardiovascular
diseases among this age group.
It is necessary to carry out further studies that contribute
toward understanding the factors related to decreased TC
and their impact on health risks in the geriatric population.
Similarly, it is also necessary to reevaluate strategies for
clinical control of dyslipidemias in older patients.
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